Embattled blood-testing company Theranos Inc. will have to face a groundbreaking securities lawsuit which seeks to recover losses on a classwide basis for investors who sank money into the privately held company.
In an eight-page order U.S. Magistrate Judge Nathanael Cousins of the Northern District of California largely denied a motion to dismiss claims filed by Theranos’ lawyers at Wilmer Cutler Pickering Hale and Dorr.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
